Menu
Mainbanner 1

What is Lanluma?

A revolutionary PLLA collagen stimulator to sculpt face and body​

Lanluma is a CE marked poly-L-lactic acid (PLLA)
injectable that sculpts, volumizes and tightens skin
of body and face. Give your patients safe*
results that last more than two years** ​

Mode of Action

​Enhance your patient’s body and face​

​Enhance your patient’s body and face​

Lanluma’s proven PLLA formula stimulates the natural collagen production for skin structure and volume restoration.​ It is quick to prepare and requires minimal downtime giving the patients a practical, safe* and efficient option to gradually sculpt their body and face.​

Tailored-made vial sizes​

Lanluma is available in two convenient sizes with identical composition to cover different areas needs: ​​

​Lanluma X: 630 mg PLLA is ideal for transforming larger areas like the buttocks.​

Lanluma V: 210 mg PLLA is perfect for small area corrections like arms, face or neck.​

HCP Packshot

Discover Lanluma’s indications and protocols​

Theface

Face

Ideal for a full face harmonization, improvement in skin quality and skin tightening​
Decolletage Necks

Décolleté and Neck

Treat flaccidity, sagging and wrinkles ​
Lanlumaweb4 Min

Abdomen

Improve skin tightness and quality. Ideal for patients with flaccidity or skin atrophy.
Buttocks

Buttocks augmentation and reshaping

Improve shape and projection. Suitable to treat hip dips.​
Legs

Thights & Cellulite

Improve skin quality to reduce cellulite. Treat inner thight and upper knee to reduce flaccidity.​
Arms

Upper arms

Suitable for correcting skin laxity.​
Hands

Hands

Ideal for ageing hands and to restore volume and skin quality.​
Access Online training

*Components used for over 30 years in the medical field.​

** J Am AcadDermatol 2010:62:448-62.​

NOTICE

Content regarding Lanluma® is not intended for patients and healthcare professionals based in Germany and Spain.

Die Inhalte zu Lanluma® sind nicht für Patienten und Ärzte mit Sitz in Deutschland bestimmt.

El contenido relacionado con Lanluma® no está destinado a pacientes y profesionales sanitarios con sede en España.

NOTICE

Content regarding Lanluma® is not intended for patients and healthcare professionals based in Germany and Spain.

Die Inhalte zu Lanluma® sind nicht für Patienten und Ärzte mit Sitz in Deutschland bestimmt.

El contenido relacionado con Lanluma® no está destinado a pacientes y profesionales sanitarios con sede en España.

INDICATION

Lanluma is a poly-L-lactic acid implant suitable for increasing the volume of depressed areas, particularly to correct skin depressions.

IMPORTANT SAFETY CONSIDERATIONS

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising. For a full list consult Instructions for Use.

The onset of any side effect must be reported immediately. Please contact the local Sinclair representative or authorised Lanluma distributor. Alternatively send the details to Sinclair on: quality@sinclair.com

For a full list of contraindications, warnings and precautions for this product please visit https://www.sinclairpharma.com/eifu for copy of the Product Instructions for Use.